Literature DB >> 29735399

Emerging Paradigm of Intracellular Targeting of G Protein-Coupled Receptors.

Madhu Chaturvedi1, Justin Schilling2, Alexandre Beautrait3, Michel Bouvier4, Jeffrey L Benovic2, Arun K Shukla5.   

Abstract

G protein-coupled receptors (GPCRs) recognize a diverse array of extracellular stimuli, and they mediate a broad repertoire of signaling events involved in human physiology. Although the major effort on targeting GPCRs has typically been focused on their extracellular surface, a series of recent developments now unfold the possibility of targeting them from the intracellular side as well. Allosteric modulators binding to the cytoplasmic surface of GPCRs have now been described, and their structural mechanisms are elucidated by high-resolution crystal structures. Furthermore, pepducins, aptamers, and intrabodies targeting the intracellular face of GPCRs have also been successfully utilized to modulate receptor signaling. Moreover, small molecule compounds, aptamers, and synthetic intrabodies targeting β-arrestins have also been discovered to modulate GPCR endocytosis and signaling. Here, we discuss the emerging paradigm of intracellular targeting of GPCRs, and outline the current challenges, potential opportunities, and future outlook in this particular area of GPCR biology.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  G protein-coupled receptors; allosteric modulators; barbadin; intrabodies; pepducins; β-arrestins

Mesh:

Substances:

Year:  2018        PMID: 29735399      PMCID: PMC7258685          DOI: 10.1016/j.tibs.2018.04.003

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  79 in total

1.  Role of endocytosis in the activation of the extracellular signal-regulated kinase cascade by sequestering and nonsequestering G protein-coupled receptors.

Authors:  K L Pierce; S Maudsley; Y Daaka; L M Luttrell; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

2.  Persistent cAMP Signaling by Internalized LH Receptors in Ovarian Follicles.

Authors:  Sandra Lyga; Silvia Volpe; Ruth C Werthmann; Konrad Götz; Titiwat Sungkaworn; Martin J Lohse; Davide Calebiro
Journal:  Endocrinology       Date:  2016-02-01       Impact factor: 4.736

3.  Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease.

Authors:  Paul A Gurbel; Kevin P Bliden; Susan E Turner; Udaya S Tantry; Martin G Gesheff; Travis P Barr; Lidija Covic; Athan Kuliopulos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-01       Impact factor: 8.311

4.  β-arrestin-biased signaling through the β2-adrenergic receptor promotes cardiomyocyte contraction.

Authors:  Richard Carr; Justin Schilling; Jianliang Song; Rhonda L Carter; Yang Du; Sungsoo M Yoo; Christopher J Traynham; Walter J Koch; Joseph Y Cheung; Douglas G Tilley; Jeffrey L Benovic
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-27       Impact factor: 11.205

Review 5.  Camelid nanobodies: killing two birds with one stone.

Authors:  Aline Desmyter; Silvia Spinelli; Alain Roussel; Christian Cambillau
Journal:  Curr Opin Struct Biol       Date:  2015-01-19       Impact factor: 6.809

6.  Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex.

Authors:  Yi-Lynn Liang; Maryam Khoshouei; Alisa Glukhova; Sebastian G B Furness; Peishen Zhao; Lachlan Clydesdale; Cassandra Koole; Tin T Truong; David M Thal; Saifei Lei; Mazdak Radjainia; Radostin Danev; Wolfgang Baumeister; Ming-Wei Wang; Laurence J Miller; Arthur Christopoulos; Patrick M Sexton; Denise Wootten
Journal:  Nature       Date:  2018-02-21       Impact factor: 49.962

7.  A general protocol for the generation of Nanobodies for structural biology.

Authors:  Els Pardon; Toon Laeremans; Sarah Triest; Søren G F Rasmussen; Alexandre Wohlkönig; Armin Ruf; Serge Muyldermans; Wim G J Hol; Brian K Kobilka; Jan Steyaert
Journal:  Nat Protoc       Date:  2014-02-27       Impact factor: 13.491

8.  Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation.

Authors:  Lidija Covic; Meghna Misra; Jehangir Badar; Christopher Singh; Athan Kuliopulos
Journal:  Nat Med       Date:  2002-09-23       Impact factor: 53.440

9.  Discovery of β2 Adrenergic Receptor Ligands Using Biosensor Fragment Screening of Tagged Wild-Type Receptor.

Authors:  Tonia Aristotelous; Seungkirl Ahn; Arun K Shukla; Sylwia Gawron; Maria F Sassano; Alem W Kahsai; Laura M Wingler; Xiao Zhu; Prachi Tripathi-Shukla; Xi-Ping Huang; Jennifer Riley; Jérémy Besnard; Kevin D Read; Bryan L Roth; Ian H Gilbert; Andrew L Hopkins; Robert J Lefkowitz; Iva Navratilova
Journal:  ACS Med Chem Lett       Date:  2013-09-03       Impact factor: 4.345

10.  Investigation of antitumor activities of trastuzumab delivered by PLGA nanoparticles.

Authors:  Barbara Colzani; Laura Pandolfi; Ada Hoti; Pietro Alessandro Iovene; Antonino Natalello; Svetlana Avvakumova; Miriam Colombo; Davide Prosperi
Journal:  Int J Nanomedicine       Date:  2018-02-14
View more
  11 in total

Review 1.  β2 Adrenergic Receptor Complexes with the L-Type Ca2+ Channel CaV1.2 and AMPA-Type Glutamate Receptors: Paradigms for Pharmacological Targeting of Protein Interactions.

Authors:  Kwun Nok Mimi Man; Manuel F Navedo; Mary C Horne; Johannes W Hell
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-09-27       Impact factor: 13.820

2.  Arrestin-β-1 Physically Scaffolds TSH and IGF1 Receptors to Enable Crosstalk.

Authors:  Christine C Krieger; Alisa Boutin; Daesong Jang; Sarah J Morgan; J Paul Banga; George J Kahaly; Joanna Klubo-Gwiezdzinska; Susanne Neumann; Marvin C Gershengorn
Journal:  Endocrinology       Date:  2019-06-01       Impact factor: 4.736

Review 3.  Advances in therapeutic peptides targeting G protein-coupled receptors.

Authors:  Anthony P Davenport; Conor C G Scully; Chris de Graaf; Alastair J H Brown; Janet J Maguire
Journal:  Nat Rev Drug Discov       Date:  2020-03-19       Impact factor: 84.694

4.  The Inside Story: Crystal Structure of the Chemokine Receptor CCR7 with an Intracellular Allosteric Antagonist.

Authors:  Shirsha Saha; Arun K Shukla
Journal:  Biochemistry       Date:  2019-11-08       Impact factor: 3.162

5.  Measuring surface expression and endocytosis of GPCRs using whole-cell ELISA.

Authors:  Shubhi Pandey; Debarati Roy; Arun K Shukla
Journal:  Methods Cell Biol       Date:  2018-11-19       Impact factor: 1.441

Review 6.  Bioluminescence Resonance Energy Transfer as a Method to Study Protein-Protein Interactions: Application to G Protein Coupled Receptor Biology.

Authors:  Chayma El Khamlichi; Flora Reverchon-Assadi; Nadège Hervouet-Coste; Lauren Blot; Eric Reiter; Séverine Morisset-Lopez
Journal:  Molecules       Date:  2019-02-01       Impact factor: 4.411

7.  Common activation mechanism of class A GPCRs.

Authors:  Qingtong Zhou; Dehua Yang; Meng Wu; Yu Guo; Wanjing Guo; Li Zhong; Xiaoqing Cai; Antao Dai; Wonjo Jang; Eugene I Shakhnovich; Zhi-Jie Liu; Raymond C Stevens; Nevin A Lambert; M Madan Babu; Ming-Wei Wang; Suwen Zhao
Journal:  Elife       Date:  2019-12-19       Impact factor: 8.140

Review 8.  Structures and Dynamics of Native-State Transmembrane Protein Targets and Bound Lipids.

Authors:  Michael Overduin; Catharine Trieber; R Scott Prosser; Louis-Philippe Picard; Joey G Sheff
Journal:  Membranes (Basel)       Date:  2021-06-17

Review 9.  New Routes in GPCR/β-Arrestin-Driven Signaling in Cancer Progression and Metastasis.

Authors:  Anna Bagnato; Laura Rosanò
Journal:  Front Pharmacol       Date:  2019-02-19       Impact factor: 5.810

10.  Structure and function of β-arrestins, their emerging role in breast cancer, and potential opportunities for therapeutic manipulation.

Authors:  Arun K Shukla; Hemlata Dwivedi-Agnihotri
Journal:  Adv Cancer Res       Date:  2020-02-05       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.